Effectiveness and safety of proton pump inhibitor and levofloxacin based first-line triple therapy in the eradication of Helicobacter pylori: A meta-analysis

National Medical Journal of China

Volumn 88, Issue 38, 2008, Pages 2722-2726

  Zhang, Zhi Feng ^a   Zhao, Gang ^a   Liu, Li Na ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Helicobacter pylori; Meta analysis

Indexed keywords

LEVOFLOXACIN; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDLINE; META ANALYSIS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OFLOXACIN; PROTON PUMP INHIBITORS;

EID: 56349161711     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials,1996,17: 1-12.
2. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ, 1997,315: 629-634.
3. Duval S, Tweedie R. A nonparametric "Trim and Fill" method of accounting for publication bias in meta-analysis. J Am Stat Assoc, 2000,95: 89-98.
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Chinese source.
8. Iacopini F, Crispino P, Paoluzi OA, et al. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Dig Liver Dis,2005,37:571-576.
9. Rispo A, Di Girolamo E, Cozzolino A, et al. Levofloxacin in first-line treatment of Helicobacter pylori infection. Helicobacter,2007, 12: 364-365.
10. Nista EC, Candelli M, Zocco MA, et al. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol,2006,101:1985-1990.
11. Chinese source.
12. Chinese source.
13. Chinese source.
14. Chinese source.
15. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther, 2002,16: 167-180.
16. Altintas E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J Gastroenterol 2004, 10: 1656-1658.
17. Gumurdulu Y, Serin E, Ozer B, et al. Lower eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey. World J Gastroent- erol 2004,10:668-671.
18. Chinese source.
19. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007,56:772-781.
20. Chinese source.